Sheng-Xiang Lin

10PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Automated software engineeringProteins and peptidesMolecular targetsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 13, 2026
Developing Potential Endocrine Therapy Controlling Estradiol and DHT by Targeting 17β-HSD7 Against ER+ Breast Cancer.

|Aug 26, 2023
Deep Drug Discovery of Mac Domain of SARS-CoV-2 (WT) Spike Inhibitors: Using Experimental ACE2 Inhibition TR-FRET Assay, Screening, Molecular Dynamic Simulations and Free Energy Calculations.

Saleem Iqbal, Sheng-Xiang Lin

|Feb 28, 2023
Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2.

Wenfa Zhang, Sheng-Xiang Lin

|Feb 25, 2022
CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer.

Xiaoye Sang, Nassira Belmessabih, Ruixuan Wang

|May 12, 2020
Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks.

Wen-Fa Zhang, Preyesh Stephen, Jean-François Thériault

|Feb 16, 2019
Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP+ reveal the mechanism of substrate inhibition.

Tang Li, Preyesh Stephen, Dao-Wei Zhu

Pageof 2

Frequent Collaborators

1 joint publications

Donald Poirier

1 joint publications

Tang Li

1 joint publications

Nassira Belmessabih

1 joint publications

Preyesh Stephen